RSSCategory: Drugs

Do pharma’s claims on drug prices pass the mell test? We found 5 stinkers.

Do pharma’s claims on drug prices pass the mell test? We found 5 stinkers.

Inventing, testing and launching a drug costs $2.6 billion, calculates the Tufts Center for the Study of Drug Development. But industry substantially finances the center’s work. An independent study found the median cost of developing 10 cancer drugs was $648 million, while the median revenue per drug was $1.7 billion.

October 2, 2017 | By | Reply More
The real reason some people become addicted to drugs

The real reason some people become addicted to drugs

Why do they do it? This is a question that friends and families often ask of those who are addicted. It’s difficult to explain how drug addiction develops over time. To many, it looks like the constant search for pleasure.

September 30, 2017 | By | Reply More
Absent federal action, states take the lead on curbing drug costs

Absent federal action, states take the lead on curbing drug costs

Despite often-fierce industry opposition, a variety of bills are working their way through state governments. California, Nevada and New York are among those joining Maryland in passing legislation meant to undercut skyrocketing drug prices.

September 29, 2017 | By | Reply More
Will Arizona’s off-label drug law spur changes elsewhere?

Will Arizona’s off-label drug law spur changes elsewhere?

When the Food and Drug Administration gives its OK for a new drug to be sold, it specifies the diseases or conditions for which the medicine has been approved. That does not mean doctors can’t prescribe that prescription drug for other diseases and conditions. They do. All the time. And it’s perfectly legal.

September 26, 2017 | By | Reply More
An ethical dilemma for doctors: When is it OK to prescribe opioids?

An ethical dilemma for doctors: When is it OK to prescribe opioids?

America’s opioid crisis is getting worse. The role of prescription opioids has both the medical establishment and the government justifiably worried.

September 25, 2017 | By | Reply More
Analysis: Everyone says we must control exorbitant drug prices. So, why don’t we?

Analysis: Everyone says we must control exorbitant drug prices. So, why don’t we?

The White House has long been expected to issue an executive order on drug costs. But leaked documents show that deliberations have focused on things the industry wants, such as extending overseas patents and changing a drug-discount program for hospitals, and not so much on lowering prices.

September 25, 2017 | By | Reply More
Attorneys general in 37 states urge insurance industry to do more to curb opioid epidemic

Attorneys general in 37 states urge insurance industry to do more to curb opioid epidemic

On Sunday, ProPublica and The New York Times reported that many insurance companies limit access to pain medications that carry a lower risk of addiction or dependence, even as they provide comparatively easy access to generic opioid medications. The safer drugs are more expensive.

September 21, 2017 | By | Reply More
Washington and other western states try to tame homegrown marijuana

Washington and other western states try to tame homegrown marijuana

Regulators in Washington, Oregon and Colorado are trying to tame what has proven to be an unruly crop of home growers. The biggest concern is that outsized home growers may be selling their produce across state lines.

September 12, 2017 | By | Reply More
Meningitis B vaccine’s high price tag poses a health care conundrum

Meningitis B vaccine’s high price tag poses a health care conundrum

Scientific evidence supporting an absolute need to immunize against meningitis B still falls short. The risk of contracting it is smaller than that of being involved in a car crash. But the headlines prompted by those 13 campus cases — which resulted in one death and one double amputation — helped reshape the financial prospects for a vaccine.

September 9, 2017 | By | Reply More
War on opioids moves to veterinarians’ offices

War on opioids moves to veterinarians’ offices

Some states are taking the war on opioids into veterinarians’ offices, aiming to prevent people who are addicted to opioids from using their pets to procure drugs for their own use.

August 23, 2017 | By | Reply More